[Takuro NIIDOME]

1. Xiao, W. Xu, Y. Komohara, Y. Fujiwara, H. Hirose, S. Futaki, T. Niidome, Effect of surface modifications on cellular uptake of gold nanorods in human primary cells and established cell lines, ACS Omega, 5, 32744-32752 (2020)
2. Ueno, M. W. Kim, G. Lee, Y. I. Park, T. Niidome, R. Lee, Development of ErbB2-targeting liposomes for enhancing drug delivery to ErbB2-positive breast cancer, Pharmaceutics, 12, 585 (2020)
3. Taharabaru, R. Yokoyama, T. Higashi, A. F. A. Mohammed, M. Inoue, Y. Maeda, T. Niidome, R. Onodera, K. Motoyama, Genome editing in a wide area of brain using dendrimer-based ternary polyplex of Cas9 ribonucleoprotein, ACS Appl. Mater. Interfaces, 12, 21386–21397 (2020)
4. Tsutsuki, T. Zhang, A. Harada, A. Rahman, K. Ono, K. Yahiro, T. Niidome, T. Sawa, Involvement of protein disulfide isomerase in Subtilase cytotoxin-induced cell death in HeLa cells, Biochem. Biophys. Res. Co., 525, 1068-1073 (2020)
5. W. Kim, G. Lee, T. Niidome, Y. Komohara, R. Lee, Y. I. Park, Platelet-like gold nanostars for cancer therapy: the ability to treat cancer and evade immune reactions, Front. Bioeng. Biotechnol., 8, 133 (2020)
6. Harada, H. Tsutsuki, T. Zhang, R. Lee, K. Yahiro, T. Sawa, T. Niidome, Preparation of biodegradable PLGA-nanoparticles used for pH-sensitive intracellular delivery of an anti-inflammatory bacterial toxin to macrophages, Chem. Pharm. Bull., 68, 363–368 (2020)
7. Xu, K. Yagoshi, T. Asakura, M. Sasaki, T. Niidome, Silk fibroin as a coating polymer for sirolimus-eluting magnesium alloy stents, ACS Applied Bio Materials, 3, 531-538 (2020)
8. Xu, K. Sato, Y. Koga, M. Sasaki, T. Niidome, Corrosion resistance of HF-treated Mg alloy stent following balloon expansion and its improvement through biodegradable polymer coating, J. Coat. Technol. Res. 17, 1023-1032 (2020)

[Ruda Lee]

1. Yong Il Park, Seung-Hae Kwon, Gibok Lee, Keiichi Motoyama, Min Woo Kim, Min Lin, Takuro Niidome, Jung Hoon Choi, Ruda Lee*. pH-sensitive multi-drug liposomes targeting folate receptor β for efficient treatment of non-small cell lung cancer.Journal of Controlled Release, 330, 1-14, February 2021.
2. Sho Ueno, Min Woo Kim, Gibok Lee, Yong Il Park, Takuro Niidome, and Ruda Lee*. Development of ErbB2-Targeting Liposomes for Enhancing Drug Delivery to ErbB2-Positive Breast Cancer. Pharmaceutics, 12, 585, June 2020.
3. Song Yeul Lee*, Ruda Lee*, Eunha Kim, Sanghee Lee and Yong Il Park. Near-Infrared Light-Triggered Photodynamic Therapy and Apoptosis Using Upconversion Nanoparticles with Dual Photosensitizers. Frontiers in Bioengineering and Biotechnology, 8, 275. Apr 2020.
4. Seung-Hae Kwon, Taemin Wi, Yong Il Park, Min Woo Kim, Gibok Lee, Takumi Higaki, Jung Hoon Choi*, and Ruda Lee*. Noninvasive Early Detection of Calpain 2‑Enriched Non-Small Cell Lung Cancer Using a Human Serum Albumin-Bounded Calpain 2 Nanosensor. Bioconjugate Chemistry, 31, 3, 803-812, Mar 2020.
5. Min Woo Kim, Gibok Lee, Takuro Niidome, Yoshihiro Komohara, Ruda Lee* and Yong Il Park*. Platelet-Like Gold Nanostars for Cancer Therapy: The Ability to Treat Cancer and Evade Immune Reactions. Frontiers in Bioengineering and Biotechnology, 8, 133. Feb 2020.
6. Sofiane Hamidi, Yukiko Nakaya, Hiroki Nagai, Cantas Alev, Takeya Kasukawa, Sapna Chhabra, Ruda Lee, Hitoshi Niwa, Aryeh Warmflash, Tatsuo Shibata, Guojun Sheng. Mesenchymal-epithelial transition regulates initiation of pluripotency exit before gastrulation. Development, 147, dev184960. Feb 2020.
7. Ruda Lee, Yu Jin Choi, Myeong Seon Jeong, Yong Il Park, Keiichi Motoyama, Min Woo Kim, Seung-Hae Kwon*, and Jung Hoon Choi*. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer. Bioconjugate Chemistry, 31, 3, 923-932, Feb 2020.
8. Ayaka Harada, Hiroyasu Tsutsuki, Tianli Zhang,Ruda Lee, Kinnosuke Yahiro, Tomohiro Sawa, Takuro Niidome, Preparation of biodegradable PLGA-nanoparticles used for pH-sensitive intracellular delivery of an anti-inflammatory bacterial toxin to macrophages. Chemical and Pharmaceutical Bulletin, 68, 4, 363-368, Jan 2020.

[Ick Chan KWON]

1. Han Young Kim, Sang Hoon Um, Yejin Sung, Man Kyu Shim, Suah Yang, Jooho Park, Eun Sun Kim, Kwangmeyung Kim, Ick Chan Kwon*, Ju Hee Ryu. Epidermal growth factor (EGF)-based activatable probe for predicting therapeutic outcome of an EGF-based doxorubicin prodrug. Journal of Controlled Release 328, 222-236, December 2020.
2. Yongwhan Choi, Hong Yeol Yoon, Jeongrae Kim, Suah Yang, Jaewan Lee, Ji Woong Choi, Yujeong Moon, Jinseong Kim, Seungho Lim, Man Kyu Shim, Sangmin Jeon, Ick Chan Kwon*, Kwangmeyung Kim. Doxorubicin-Loaded PLGA Nanoparticles for Cancer Therapy: Molecular Weight Effect of PLGA in Doxorubicin Release for Controlling Immunogenic Cell Death. Pharmaceutics 12, 1165, December 2020.
3. Ju Hee Ryu, Hong Yeol Yoon, In‐Cheol Sun, Ick Chan Kwon*, Kwangmeyung Kim. Tumor‐Targeting Glycol Chitosan Nanoparticles for Cancer Heterogeneity. Advanced Materials 32, 2002197, December 2020.
4. Yongwhan Choi, Hyounkoo Han, Sangmin Jeon, Hong Yeol Yoon, Hyuncheol Kim, Ick Chan Kwon*, Kwangmeyung Kim. Deep Tumor Penetration of Doxorubicin-Loaded Glycol Chitosan Nanoparticles Using High-Intensity Focused Ultrasound. Pharmaceutics 12, 974, October 2020.
5. Young Ji Ko, Jong Won Lee, Hyosuk Kim, EunJi Cho, Yoosoo Yang, In-San Kim, Sun Hwa Kim, Ick Chan Kwon*. Versatile activatable vSIRPα-probe for cancer-targeted imaging and macrophage-mediated phagocytosis of cancer cells. Journal of Controlled Release 323,376-386, July 2020.
6. Gi Beom Kim, Gi-Hoon Nam, Yeonsun Hong, Jiwan Woo, Yakdol Cho, Ick Chan Kwon, Yoosoo Yang, In-San Kim. Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity. Science Advances 2, eaaz2083, July 2020.
7. Jiwon Kim, Hee Jeong Jang, Dawid Schellingerhout, Jeong Wook Kang, Seungbum Choi, Hyerin Oh, Eo Jin Kim, Su-Kyoung Lee, Ji Sung Lee, Ick Chan Kwon, Kwangmeyung Kim, Young Jun Koh, Wi-Sun Ryu, Dong-Eog Kim. Effects of exercise training and detraining on atheromatous matrix metalloproteinase activity in mice. Atherosclerosis 299, 15023, April 2020.
8. Min Ju Kim, So Jin Lee, Ju Hee Ryu, Sun Hwa Kim, Ick Chan Kwon*, Thomas M Roberts. Combination of KRAS gene silencing and PI3K inhibition for ovarian cancer treatment. Journal of Controlled Release 318, 98-108, February 2020.
9. Sun Young Wang, Hyosuk Kim, Gijung Kwak, Sung Duk Jo, Daeho Cho, Yoosoo Yang, Ick Chan Kwon, Ji Hoon Jeong, Sun Hwa Kim. Development of microRNA-21 mimic nanocarriers for the treatment of cutaneous wounds. Theranostics 10, 3240, January 2020.
10. Manse Kim, Abhishek Sahu, Youngmin Hwang, Gi Beom Kim, Gi Hoon Nam, In-San Kim, Ick Chan Kwon*, Giyoong Tae. Targeted delivery of anti-inflammatory cytokine by nanocarrier reduces atherosclerosis in Apo E−/-mice. Biomaterials 226, 119550, January 2020.
11. Young Ji Ko, Jae-Won Lee, Eun-Jeong Yang, Nayoon Jang, Jooho Park, Yoon Kyung Jeon, Je-Wook Yu, Nam-Hyuk Cho, Hye-Sun Kim, Ick Chan Kwon*. Non-invasive in vivo imaging of caspase-1 activation enables rapid and spatiotemporal detection of acute and chronic inflammatory disorders. Biomaterials 226, 119534, January 2020.

[Keiichi MOTOYAMA & Taishi HIGASHI]

1. Lactose-appended β-cyclodextrin as an effective nanocarrier for brain delivery. R. Yokoyama, T. Taharabaru, T. Nishida, Y. Ohno, Y. Maeda, M. Sato, K. Ishikura, K. Yanagihara, H. Takagi, T. Nakamura, S. Ito, S. Ohtsuki, H. Arima, R. Onodera, Higashi, K. Motoyama, J. Control. Release, 328, 722-735 (2020).
2. Improvement of pharmaceutical properties of Zerumbone, a multifunctional compound, using cyclodextrin derivatives. Md. M. Hassan, A.F.A. Mohammed, K.M. Elamin, H.P. Devkota, Y. Ohno, Motoyama, T. Higashi, T. Imai, Chem. Pharm. Bull., 68, 1117-1120 (2020).
3. Efficient anticancer drug delivery for pancreatic cancer treatment utilizing supramolecular polyethylene-glycosylated bromelain. Higashi, T. Kogo, N. Sato, T. Hirotsu, S. Misumi, H. Nakamura, D. Iohara, R. Onodera, K. Motoyama, H. Arima, ACS Appl. Bio Mater., 3, 3005-3014 (2020).
4. Folate-appended cyclodextrin improves the intratumoral accumulation of existing boron compounds. Y. Matsumoto, K. Hattori, H. Arima, Motoyama, T. Higashi, H. Ishikawa, N. Fukumitsu, T. Aihara, K. Nakai, H. Kumada, H. Sakurai, Appl. Radiat. Isot., 163, 109201 (2020).
5. Genome editing in a wide area of the brain using dendrimer-based ternary polyplexes of Cas9 ribonucleoprotein. T. Taharabaru, R. Yokoyama, Higashi, A.F.A. Mohammed, M. Inoue, Y. Maeda, T. Niidome, R. Onodera, K. Motoyama, ACS Appl. Mater. Interfaces, 12, 21386-21397 (2020).
6. Differential effects of 2-hydroxypropyl-cyclodextrins on lipid accumulation in Npc1-null cells. S. Hoque, Y. Kondo, N. Sakata, Y. Yamada, M. Fukaura, Higashi, K. Motoyama, H. Arima, K. Higaki, A. Hayashi, T. Komiya, Y. Ishitsuka, T. Irie, Int. J. Mol. Sci., 21, 898 (2020).
7. Nanoparticle drug delivery systems for α-mangostin. N. Wathoni, A. Rusdin, Motoyama, I.M. Joni, R. Lesmana, M. Muchtaridi, Nanotechnol. Sci. Appl., 13, 23-36 (2020).
8. Hyaluronic Acid-Decorated Glycol Chitosan Nanoparticles for pH-Sensitive Controlled Release of Doxorubicin and Celecoxib in Nonsmall Cell Lung Cancer. R. Lee, Y.J Choi, M.y.S Jeong, Y.Il. Park, Motoyama, M.W. Kim, S.H. Kwon, J.H. Choi, Bioconjug. Chem., 31, 923-932 (2020).
9. A thermoresponsive hydrophobically modified hydroxypropylmethyl cellulose/cyclodextrin injectable hydrogel for the sustained release of drugs. M. Okubo, D. Iohara, M. Anraku, Higashi, K. Uekama, F. Hirayama, Int. J. Pharm., 575, 118845 (2020).